Studies suggesting that a cancer diagnosis reduces the risk of Alzheimer’s disease (AD), possibly through a biological mechanism that triggers cancer and prevents AD, may be somewhat irrelevant, researchers said, pointing to data showing that pancreatic cancer patients usually don’t live long enough to develop Alzheimer’s. The study, “Is…
Men undergoing androgen deprivation therapy (ADT) for prostate cancer could be almost twice as likely to be diagnosed with Alzheimer’s disease (AD) than those not treated with ADT. The findings, in a study published in the Journal of Clinical Oncology, also show that the risks of developing Alzheimer’s might continue…
A recent study published in the Journal of Alzheimer’s Disease titled “A Clinical Study of Lupron Depot in the Treatment of Women with Alzheimer’s Disease: Preservation of Cognitive Function in Patients Taking an Acetylcholinesterase Inhibitor and Treated with High Dose Lupron Over 48 Weeks“ showed that women…
Get regular updates to your inbox.